|
|
News for Healthier Living
Real-World Study Provides New Insights into Safety of New Alzheimer's Drug
 Researchers at Duke Health studied more than 230 patients treated with lecanemab, a new FDA-approved therapy (known as an anti-amyloid therapy) designed to remove a protein linked to Alzheimer's disease from the brain.
They found the therapy's real-world safety, treatment persistence, and effects on disease progession aligned with results from clinical trials - including the most closely watched side effect, which involves brain swelling or bleeding, commonly referred to as Amyloid Related Imaging Abnormalities (ARIA).
August 7, 2026
August 7 2026August 6 2026 - International Study Identifies Promising Therapy to Prevent Relapses in Rare Neurological Disease
- New Study Finds Bacterial Infections Affect About 1 in 20 Hospitalized Adults With Firearm Injuries
- University of Michigan Health Liver Transplant Program Earns Top Five National Ranking for Transplant Access
- State of Michigan Allows Tax Credit for Private Employers of Living Organ Donors
- How Age Shapes Treatment Decisions in Chronic Coronary Disease
- Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- Finding New Osteoarthritis Medicines Via AI and Genetics
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- New CDC Director Dr. Erica Schwartz Takes Over
- Three Midlife Habits That Could Help Protect Your Brain
- New research center set to explore treatments for Alzheimer's
- New U.S. Disease Tracker strengthens monitoring of vaccine-preventable diseases
- Protein 'Switch' Determines Whether Liposarcoma Cells Will Become Aggressive, Roswell Park Expert Reports
- Penn Nursing Professors Co-author Editorial on the Impact of Trauma, Stress, and Violence on Health
- Trial Focuses on Duration of Therapeutic Hypothermia for Out-of-Hospital Cardiac Arrests
- Research: Steam Increases Physiological Strain During Sauna Bathing
- A Drop That Can Save the Sight of Extremely Premature Babies
- From X Chromosome Silencing to Therapy: New Strategies for Treating X-Linked Disorders
- DXA Testing for Osteoporosis Screening Declined 35% Among Medicare Beneficiaries Over Nearly Two Decades
- Want Strong Bones? Review Says Vigorous Sports Like Handball Beat Walking, Strength Training
- Germs From Pet Dogs Might Protect Infants Against Infection, Researchers Say
- Parenting Can Offset ADHD Risk In Toddlers, Study Says
- Expert Shares Practical Tips for Treating Hair Loss
- Nurses Chase Cyclospora, Aided By Interviews, Fast-Food Receipts — And The Messy Details
- Innosuisse Flagship project for the prevention of type 2 diabetes
- Vascular and Musculoskeletal Interactions: Structure, Function, and Therapeutic Strategies for Sarcopenia and Osteoporosis
- Brain-body interactions in systemic diseases: a survey from an imaging perspective
- Essential genetic mutations impair DNA damage repair and modulate tumor immune microenvironment in ccRCC
- Proteogenomics: Decoding Cancer in Multiple Dimensions
August 5 2026August 4 2026August 3 2026August 1 2026July 31 2026July 30 2026July 29 2026July 28 2026July 27 2026July 26 2026
|
|
|
|
|